PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365A959. A total of 3 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 600 | -14.3% | 0.00% | – |
| Q2 2023 | $1 | – | 700 | +75.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 400 | -63.6% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 1,100 | -26.7% | 0.00% | – |
| Q3 2022 | $1,000 | -99.0% | 1,500 | -98.3% | 0.00% | – |
| Q2 2022 | $98,000 | 0.0% | 90,100 | -2.8% | 0.00% | – |
| Q1 2022 | $98,000 | +880.0% | 92,700 | +641.6% | 0.00% | – |
| Q4 2021 | $10,000 | -98.2% | 12,500 | -95.8% | 0.00% | -100.0% |
| Q3 2021 | $551,000 | -2.1% | 295,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $563,000 | +270.4% | 295,000 | +85905.8% | 0.00% | – |
| Q1 2021 | $152,000 | +322.2% | 343 | +243.0% | 0.00% | – |
| Q4 2020 | $36,000 | +414.3% | 100 | +426.3% | 0.00% | – |
| Q3 2020 | $7,000 | +133.3% | 19 | +90.0% | 0.00% | – |
| Q2 2020 | $3,000 | +200.0% | 10 | +100.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 3,100 | $5,146 | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 279 | $43,524 | 0.00% |
| SIMPLEX TRADING, LLC | 600 | $0 | 0.00% |